rs201352768
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.3925G>A(p.Val1309Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000549 in 1,611,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1309F) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.3886G>A | p.Val1296Ile | missense_variant | Exon 19 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.3886G>A | p.Val1296Ile | missense_variant | Exon 19 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.3925G>A | p.Val1309Ile | missense_variant | Exon 19 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.3975G>A | non_coding_transcript_exon_variant | Exon 19 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*1838G>A | non_coding_transcript_exon_variant | Exon 19 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*3372G>A | non_coding_transcript_exon_variant | Exon 18 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.3925G>A | non_coding_transcript_exon_variant | Exon 19 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000640028.1 | n.*1838G>A | 3_prime_UTR_variant | Exon 19 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*3372G>A | 3_prime_UTR_variant | Exon 18 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000343 AC: 52AN: 151532Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.000461 AC: 114AN: 247246 AF XY: 0.000490 show subpopulations
GnomAD4 exome AF: 0.000571 AC: 833AN: 1459848Hom.: 0 Cov.: 38 AF XY: 0.000580 AC XY: 421AN XY: 726260 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000343 AC: 52AN: 151532Hom.: 0 Cov.: 27 AF XY: 0.000325 AC XY: 24AN XY: 73908 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
CACNA1H-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at